Correlation of Triglyceride-Glucose Index with Diabetic Retinopathy in Diabetic Patients in Nepal: A Cross-Sectional Analysis - Top-Institutions - MDSpire

Correlation of Triglyceride-Glucose Index with Diabetic Retinopathy in Diabetic Patients in Nepal: A Cross-Sectional Analysis

  • By

  • Saurav Thapa

  • Anup Ghimire

  • Bijay Kunwar

  • Binay Aryal

  • Aramva Bikram Adhikari

  • Arati Karakheti

  • Mani Prasad Gautam

  • February 7, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Joslin Diabetes Center
    Joslin Diabetes Center

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Diabetes Research
    • Ophthalmology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Ophthalmology
    • Metabolic Research

  • #3

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Ophthalmology
    • Clinical Epidemiology

  • #4

    All India Institute of Medical Sciences (AIIMS)
    All India Institute of Medical Sciences (AIIMS)

    New Delhi, Delhi

    Key Differentiators

    • Endocrinology
    • Ophthalmology
    • Public Health

  • #5

    Singapore National Eye Centre (SNEC)
    Singapore National Eye Centre (SNEC)

    Singapore, N/A

    Key Differentiators

    • Ophthalmology
    • Diabetes Research
    • Metabolic Disorders

Original Source(s)

Correlation of Triglyceride-Glucose Index with Diabetic Retinopathy in Diabetic Patients in Nepal: A Cross-Sectional Analysis

  • by Saurav Thapa, Anup Ghimire, Bijay Kunwar, Binay Aryal, Aramva Bikram Adhikari, Arati Karakheti, Mani Prasad Gautam

  • February 7, 2026

Related Content

Progress and Obstacles in Understanding Pathological Mechanisms and Developing Intelligent Diagnostic Approaches for Diabetic Optic Neuropathy

Clinical spectrum of extreme insulin resistance syndromes treated with rhIGF-1: A single-center experience

AI Screening for Diabetic Retinopathy